Crinetics Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
SAN DIEGO, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that company management will participate in a fireside chat and one-on-one investor meetings at the 4th Annual Evercore ISI HealthCONx Conference, which is taking place virtually November 30, 2021 through December 2, 2021.
Details on the fireside chat can be found below.
A webcast of the fireside chat will also be accessible on the Events & Presentations page in the Investors section ofthe Crinetics website. A replay of the fireside chat will be available at the same location following its conclusion and will be archived for 90 days.
About Crinetics Pharmaceuticals
Investors / Media:
Solutions Showcase - Battle for the ROI
The Need for Speed: How Fast can 6G Transmit?
ITEXPO #TECHSUPERSHOW Expo Hall Open